[ad_1] Drugmaker Acelyrin has raised $540 million through an initial public offering despite a chilly market for biotechnology companies seeking to make their stock-market debuts. Acelyrin, based in the Los…
Tag: Acelyrin
Biopharma firm Acelyrin valued at $2.1 billion in strong market debut
[ad_1] May 5 (Reuters) – Shares of Acelyrin Inc (SLRN.O) rose 28% in their Nasdaq debut on Friday, giving the biopharma company a market capitalization of $2.1 billion. The Los…